October 12-16, 2026 | Bell Harbor International Conference Center, Seattle, WA

17th Annual In-Person Comprehensive Hematology & Oncology Review Course

Join us for the 17th Annual Hematology and Oncology Review Course, hosted by Fred Hutch Cancer Center and UW Medicine, taking place October 12-16, 2026 in Seattle, WA.

This accredited, multi-day, in-person symposium offers a unique opportunity to deepen your clinical expertise and connect with nationally recognized leaders in hematologic and oncologic care. Designed for practicing physicians and advanced providers, this comprehensive educational program delivers the latest updates in evidence-based standards, emerging therapies, and evolving guidelines across the spectrum of hematology and medical oncology.

Whether you're seeking to refine your clinical decision-making or stay ahead of the curve in a rapidly advancing field, this course provides the insights and peer engagement that make it a standout event year after year.

Intended Audience

This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, allied health professionals, residents, and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.

Learning Objectives

Upon completion of this activity, learners should be able to:

  1. Explain the pathogenesis, diagnostic evaluation strategies, and evidence‑based treatment options for common malignant hematologic diseases, and apply this knowledge to collaborative care planning.
  2. Explain the pathogenesis, diagnostic workup, and current therapeutic modalities for common solid tumor malignancies, and integrate this information into team-based decision‑making.
  3. Apply national guidelines and consensus recommendations to develop individualized, patient‑centered treatment plans that incorporate clinical, psychosocial, and patient‑preference factors.
  4. Evaluate and incorporate emerging therapies, diagnostics, and clinical trial data into practice to optimize outcomes across the interprofessional care continuum.
  5. Collaborate effectively within the interprofessional team to identify care gaps, coordinate management strategies, and improve quality and safety in oncology care delivery.

 

Location

Bell Harbor International Conference Center

2211 Alaskan Way
Seattle, WA 98121

Accreditation

Joint Accreditation: In support of improving patient care, The University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

ACCME: The University of Washington School of Medicine designates this Live Activity for a maximum of 37.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ANCC: The University of Washington School of Medicine designates this activity for a maximum of 37.25 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

 

Maintenance of Certification (MOC) Credits

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 37.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.